Our Board of Directors
Our board is comprised of years of leadership and professional experience; each is committed to our mission to raise awareness and funds in the fight against pediatric cancer.
NCI News Releases
11 December 2019
The latest cancer news from the U.S. government's principal agency for cancer research.-
Immunotherapy drug improves outcomes for some children with relapsed leukemia
For children and young adults with certain relapsed B-cell acute lymphoblastic leukemia (B-ALL), the immunotherapy drug blinatumomab is superior to standard chemotherapy, an NCI-sponsored Children’s Oncology Group trial shows.
-
Study quantifies impact of NCI-sponsored trials on clinical cancer care
Nearly half of phase 3 cancer clinical trials carried out by the NCI-sponsored SWOG Cancer Research Network were associated with clinical care guidelines or new drug approvals, a study in JAMA Network Open shows.
-
NCI study finds long-term increased risk of cancer death following common treatment for hyperthyroidism
Findings from a new NCI study of patients who received radioactive iodine (RAI) treatment for hyperthyroidism show an association between the dose of treatment and long-term risk of death from solid cancers, including breast cancer.
NCI Fact Sheets
11 December 2019
The latest NCI fact sheets on a wide array of cancer topics including risk factors, prevention, support, treatment, and more.-
Tumor Markers
A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.
-
Targeted Cancer Therapies
A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.
-
Genetic Testing for Inherited Cancer Susceptibility Syndromes
A fact sheet about genetic testing for inherited cancer risk, including who should consider testing, how to understand test results, and who has access to a person’s test results. Also contains information about at-home, or direct-to-consumer, genetic tests.
